clarithromycin has been researched along with Hemolysis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chetchotisakd, P; Faksri, K; Kaewprasert, O; Kanthawong, S; Roytrakul, S; Sirichoat, A; Sudadech, P | 1 |
| Arya, R; Cheon, DH; Choi, Y; Chong, YP; Choo, S; Hyun, S; Jin, SM; Jo, D; Kim, KK; Kim, S; Kim, YS; Lee, S; Lee, Y; Park, S; Park, SJ; Park, TW; Yoo, W; Yu, J | 1 |
| Huang, E; Meeker, DG; Moon, SH; Smeltzer, MS; Zhang, X; Zheng, G | 1 |
| He, H; Jin, X; Li, H; Liu, X; Qi, N; Sun, W; Tang, X; Tian, B; Zhang, B | 1 |
| Guo, CT; Hasegawa, S; Hidari, K; Hiramatsu, H; Miyamoto, D; Sakano, Y; Sriwilaijaroen, N; Suzuki, T; Suzuki, Y; Takahashi, T; Yingsakmongkon, S | 1 |
| Anderson, R; Feldman, C; Theron, AJ | 1 |
6 other study(ies) available for clarithromycin and Hemolysis
| Article | Year |
|---|---|
Assessment of in vitro activities of novel modified antimicrobial peptides against clarithromycin resistant Mycobacterium abscessus.
Topics: Antimicrobial Peptides; Clarithromycin; Drug Resistance, Bacterial; Erythrocytes; Genome, Bacterial; Hemolysis; Humans; Microbial Sensitivity Tests; Microbial Viability; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Whole Genome Sequencing | 2021 |
Proline Hinged Amphipathic α-Helical Peptide Sensitizes Gram-Negative Bacteria to Various Gram-Positive Antibiotics.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cell Membrane; Clarithromycin; Escherichia coli; Female; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Linezolid; Lipid A; Membrane Fluidity; Mice, Inbred ICR; Microbial Sensitivity Tests; Proline; Protein Binding; Protein Conformation, alpha-Helical; Rifampin | 2020 |
Novel Linear Lipopeptide Paenipeptins with Potential for Eradicating Biofilms and Sensitizing Gram-Negative Bacteria to Rifampicin and Clarithromycin.
Topics: Anti-Bacterial Agents; Biofilms; Clarithromycin; Drug Synergism; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hemolysis; Humans; Lipopeptides; Microbial Sensitivity Tests; Paenibacillus; Rifampin; Structure-Activity Relationship | 2017 |
Clarithromycin-loaded liposomes offering high drug loading and less irritation.
Topics: Animals; Anti-Bacterial Agents; Calorimetry, Differential Scanning; Chromatography, High Pressure Liquid; Clarithromycin; Crystallization; Drug Compounding; Drug Stability; Erythrocytes; Freeze Drying; Hemolysis; Injections, Intravenous; Liposomes; Mice; Microscopy, Electron, Transmission; Molecular Structure; Pain; Particle Size; Rabbits; Rats; Skin; Skin Irritancy Tests; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties | 2013 |
Clarithromycin inhibits progeny virus production from human influenza virus-infected host cells.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Clarithromycin; Dogs; Enzyme Inhibitors; Hemagglutination Inhibition Tests; Hemolysis; Humans; Influenza A virus; Neuraminidase; Viral Plaque Assay; Virus Replication | 2008 |
Investigation of the anti-inflammatory and membrane-stabilizing potential of spiramycin in vitro.
Topics: Adult; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Erythrocyte Membrane; Hemolysis; Humans; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Sheep; Spiramycin; Superoxides | 2000 |